T1	Disease 126 131	NSCLC
#1	AnnotatorNotes T1	DOID:3908
T10	Biomarker 519 559	decreased levels of pMAP2K1 and pMAPK1/3
T11	Disease 563 568	SCC-R
T12	Drug 668 677	erlotinib
T14	Biomarker 701 745	activation of Ras/Raf/Mek/Erk signaling axis
T15	Disease 855 860	HNSCC
T16	Biomarker 875 916	mRNA overexpression of MAPK pathway genes
T17	Disease 942 947	HNSCC
T19	Biomarker 1001 1013	MAPK pathway
T2	Drug 154 163	erlotinib
T20	Disease 1057 1062	HNSCC
T21	Biomarker 1086 1098	MAPK pathway
T22	Disease 1141 1146	HNSCC
T4	Drug 231 241	PD-0325901
T6	Drug 285 295	PD-0325901
T7	Disease 255 260	SCC-S
T8	Drug 415 425	PD-0325901
T9	Drug 496 506	PD-0325901
T23	GeneFamily 110 114	MAPK
T24	GeneFamily 600 604	MAPK
T25	GeneFamily 898 902	MAPK
T27	GeneFamily 1001 1005	MAPK
T26	GeneFamily 1086 1090	MAPK
T28	Gene-Protein 211 219	MAP2K1/2
T29	Gene-Protein 469 475	MAP2K1
T30	Gene-Protein 539 546	pMAP2K1
T31	Gene-Protein 551 559	pMAPK1/3
T32	GeneFamily 799 803	MAPK
R1	Association Arg1:T19 Arg2:T20	
R2	Association Arg1:T21 Arg2:T22	
T18	Biomarker 782 847	Genes related to MAPK pathway are altered at a frequency of 4â€“15%
R3	Association Arg1:T16 Arg2:T17	
R4	Association Arg1:T18 Arg2:T15	
#3	AnnotatorNotes T23	family:651
T33	Drug-Class 211 229	MAP2K1/2 inhibitor
#5	AnnotatorNotes T4	CHEMBL507361
T34	Gene-Protein 381 387	MAP2K1
#6	AnnotatorNotes T2	CHEMBL553
T35	Disease 154 179	erlotinib-resistant SCC-R
#7	AnnotatorNotes T35	not found
R5	Response Arg1:T4 Arg2:T35	
R6	Response Arg1:T6 Arg2:T7	
T3	GeneFamily 715 718	Ras
T36	GeneFamily 719 722	Raf
T37	GeneFamily 723 726	Mek
T38	GeneFamily 727 730	Erk
T39	Disease 668 693	erlotinib resistant SCC-R
R7	Association Arg1:T14 Arg2:T39	
#2	AnnotatorNotes T15	DOID:5520
#4	AnnotatorNotes T7	not found
#8	AnnotatorNotes T11	not found
